Institutional investors purchased a net $2.3 million shares of DNDN during the quarter ended June 2014 and now own 34.27% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
QUOTIENT INVESTORS LLC Bought 140.2 Thousand shares of Dendreon Corp
STATE TEACHERS RETIREMENT SYSTEM... Bought 74.0 Thousand shares of Dendreon Corp
CREATIVE PLANNING, INC. Bought 8.0 Thousand shares of Dendreon Corp